Sana Biotechnology Inc has a consensus price target of $12.57, established from looking at the 12 latest analyst ratings. The last 3 analyst ratings were released from JMP Securities, HC Wainwright & Co., and HC Wainwright & Co. on March 1, 2024, March 1, 2024, and January 16, 2024. With an average price target of $13 between JMP Securities, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 30.94% upside for Sana Biotechnology Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/01/2024 | SANA | Buy Now | Sana Biotechnology | $9.93 | 51.09% | JMP Securities | Reni Benjamin | $8 → $15 | Maintains | Market Outperform | Get Alert |
03/01/2024 | SANA | Buy Now | Sana Biotechnology | $9.93 | 20.87% | HC Wainwright & Co. | Emily Bodnar | → $12 | Reiterates | Buy → Buy | Get Alert |
01/16/2024 | SANA | Buy Now | Sana Biotechnology | $9.93 | 20.87% | HC Wainwright & Co. | Emily Bodnar | → $12 | Upgrade | Neutral → Buy | Get Alert |
10/12/2023 | SANA | Buy Now | Sana Biotechnology | $9.93 | -19.42% | JMP Securities | Reni Benjamin | $9 → $8 | Maintains | Market Outperform | Get Alert |
09/25/2023 | SANA | Buy Now | Sana Biotechnology | $9.93 | -9.35% | JMP Securities | Reni Benjamin | → $9 | Initiates | → Market Outperform | Get Alert |
09/05/2023 | SANA | Buy Now | Sana Biotechnology | $9.93 | -19.42% | Citigroup | Samantha Semenkow | → $8 | Initiates | → Buy | Get Alert |
08/14/2023 | SANA | Buy Now | Sana Biotechnology | $9.93 | — | TD Cowen | Marc Frahm | — | Initiates | → Market Perform | Get Alert |
05/02/2023 | SANA | Buy Now | Sana Biotechnology | $9.93 | — | HC Wainwright & Co. | Emily Bodnar | — | Initiates | → Neutral | Get Alert |
01/24/2023 | SANA | Buy Now | Sana Biotechnology | $9.93 | 30.94% | Morgan Stanley | Matthew Harrison | $15 → $13 | Maintains | Overweight | Get Alert |
11/03/2022 | SANA | Buy Now | Sana Biotechnology | $9.93 | -39.56% | Goldman Sachs | Salveen Richter | $7 → $6 | Maintains | Neutral | Get Alert |
05/17/2022 | SANA | Buy Now | Sana Biotechnology | $9.93 | 51.09% | Morgan Stanley | Matthew Harrison | $17 → $15 | Maintains | Overweight | Get Alert |
08/06/2021 | SANA | Buy Now | Sana Biotechnology | $9.93 | 242.47% | Goldman Sachs | — | — | Maintains | Neutral | Get Alert |
The latest price target for Sana Biotechnology (NASDAQ: SANA) was reported by JMP Securities on March 1, 2024. The analyst firm set a price target for $15.00 expecting SANA to rise to within 12 months (a possible 51.09% upside). 8 analyst firms have reported ratings in the last year.
The latest analyst rating for Sana Biotechnology (NASDAQ: SANA) was provided by JMP Securities, and Sana Biotechnology maintained their market outperform rating.
The last upgrade for Sana Biotechnology Inc happened on January 16, 2024 when HC Wainwright & Co. raised their price target to $12. HC Wainwright & Co. previously had a neutral for Sana Biotechnology Inc.
There is no last downgrade for Sana Biotechnology.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sana Biotechnology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sana Biotechnology was filed on March 1, 2024 so you should expect the next rating to be made available sometime around March 1, 2025.
While ratings are subjective and will change, the latest Sana Biotechnology (SANA) rating was a maintained with a price target of $8.00 to $15.00. The current price Sana Biotechnology (SANA) is trading at is $9.93, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.